Yutaka Niihara - 18 Jun 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Issuer symbol
EMMA
Transactions as of
18 Jun 2021
Net transactions value
+$3,578
Form type
4
Filing time
22 Jun 2021, 17:09:01 UTC
Previous filing
17 Jun 2021
Next filing
28 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $795 +500 +0% $1.59* 10,764,121 18 Jun 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $1,988 +1,250 +0.01% $1.59* 10,765,371 21 Jun 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $795 +500 +0% $1.59* 10,765,871 22 Jun 2021 Direct F1
holding EMMA Common stock, $0.001 par value 92,794 18 Jun 2021 By Hope International Hospice, Inc. F2
holding EMMA Common stock, $0.001 par value 63,000 18 Jun 2021 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F2 Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.